Hybrid Conferencee

International Conference on Rheumatology and Autoantibody Studies (ICRAAS - 26)

29th - 30th December 2026 | Giza, Egypt

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Giza. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Giza event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Giza conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Giza, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Giza."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Autoantibody Research

This track will explore the latest findings in autoantibody research, focusing on their role in the pathogenesis of rheumatic diseases. Participants will discuss novel biomarkers and their implications for early diagnosis and treatment strategies.

Track 02

Molecular Diagnostics in Rheumatology

This session will highlight cutting-edge molecular diagnostic techniques that enhance the understanding of rheumatic diseases. Emphasis will be placed on the integration of these technologies into clinical practice for improved patient outcomes.

Track 03

Translational Research in Autoimmunity

This track will address the challenges and successes of translating basic research findings into clinical applications in rheumatology. Discussions will focus on bridging the gap between laboratory discoveries and patient care.

Track 04

Innovative Therapeutic Strategies

Participants will examine novel therapeutic approaches for managing rheumatic diseases, including biologics and small molecules. The session aims to evaluate the efficacy and safety of these treatments in diverse patient populations.

Track 05

Clinical Research Methodologies in Rheumatology

This track will cover various clinical research methodologies employed in rheumatology studies, including randomized controlled trials and observational studies. The focus will be on enhancing research design to yield robust and reliable results.

Track 06

Patient-Centered Care in Rheumatology

This session will emphasize the importance of patient-centered approaches in the management of rheumatic diseases. Discussions will include strategies for improving patient engagement and adherence to treatment plans.

Track 07

Laboratory Techniques in Autoantibody Testing

This track will delve into the laboratory techniques used for the detection and characterization of autoantibodies. Participants will share best practices and innovations that enhance diagnostic accuracy.

Track 08

Biomarker Discovery in Rheumatic Diseases

This session will focus on the identification and validation of biomarkers that can predict disease progression and treatment response in rheumatology. The implications of these discoveries for personalized medicine will be discussed.

Track 09

Immunological Mechanisms in Rheumatology

This track will explore the immunological mechanisms underlying rheumatic diseases, including the role of immune cells and cytokines. Participants will discuss how these insights can inform therapeutic interventions.

Track 10

Epidemiology of Autoimmune Disorders

This session will examine the epidemiological trends and risk factors associated with autoimmune disorders, particularly in rheumatology. Insights gained will inform public health strategies and resource allocation.

Track 11

Future Directions in Rheumatology Research

This track will provide a platform for discussing emerging trends and future directions in rheumatology research. Participants will explore innovative approaches that hold promise for transforming the field.